课题基金 / 基金详情

MULTIPLE DRUG RESISTANCE IN HUMAN SOLID TUMORS

MULTIPLE DRUG RESISTANCE IN HUMAN SOLID TUMORS
人类实体瘤的多重耐药性
批准号:
3187515
负责人:
Awtar Ganju-Krishan
金额:
$17.1万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-05-01 至 1992-04-30

项目摘要

项目成果

Awtar Ganju-Krishan的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Multiple Drug Resistance (MDR) is a major reason for failure of cancer chemotherapy. Earlier studies on murine cell lines have identified certain biochemical mechanisms (e.g. rapid drug efflux) responsible for MDR. Cellular markers such as cell surface glycoproteins are often associated with MDR. Our knowledge about MDR in solid tumors is limited and it is important to study drug resistance in human soild tumors, as more often than not, MDR results in treatment failure. In the present study, we propose to study MDR in human solid tumor cells isolated from ascites and pleural fluid of patients and from xenografts earlier established. We will use our laser excitation method to sort and study tumor cells on the basis of their anthracycline fluorescence content. Drug transport characteristics will be studied with or without exposure to drug efflux blockers. Biochemical mechanisms responsible for MDR as well as well-known markers of MDR will be studied. It is hoped that the studies proposed will provide insights into mechanisms involved in MDR of human solid tumors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Flow Cytometry to Detect Human Tumor Cells in Body Fluid
Flow Cytometry to Detect Human Tumor Cells in Body Fluid
COULTER ELITE ESP CELL SORTER
SMALL INSTRUMENTATION GRANT